Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: A phase I clinical trial

Human Gene Therapy

Volumn 8, Issue 1, 1997, Pages 15-25

  Bellon, Gabriel ^a   Michel Calemard, Laurence ^a   Thouvenot, Danièle ^a   Jagneaux, Véronique ^a   Poitevin, Françoise ^a   Malcus, Christophe ^a   Accart, Nathalie ^b   Layani, Marie Pierre ^a   Aymard, Michèle ^a   Bernon, Hélène ^a   Bienvenu, Jacques ^a   Courtney, Michael ^b   Döring, Gerd ^a   Gilly, Bernard ^b   Gilly, Robert ^a   Lamy, Didier ^b   Levrey, Hélène ^a   Morel, Yves ^a   Paulin, Christian ^a   Perraud, Frédéric ^b   Rodillon, Laurence ^a   Sené, Claude ^b   So, Satta ^a   Touraine Moulin, Françoise ^a   Schatz, Christian ^b   Pavirani, Andrea ^b   more..

^a HOSPICES CIVILS DE LYON   (France)

^b TRANSGENE S A   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR; VIRUS ANTIBODY; VIRUS DNA;

ADENOVIRUS; ADULT; AEROSOL; AIRWAY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; MALE; NONHUMAN; NOSE; PHASE 1 CLINICAL TRIAL; VIRUS RECOMBINANT;

EID: 16944367323     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.1-15     Document Type: Article

References (39)

1. ALTON, E.W.F.W., CURRIE, D., LOGANSINCLAIR, R., WARNER, J.O., HODSON, M.E., and GEDDES, D.M. (1990). Nasal potential difference - A clinical diagnostic test for cystic fibrosis. Eur. Respir. J. 8, 922-926.
2. ALTON, E.W.F.M., and GEDDES, D.M. (1995). Gene therapy for cystic fibrosis: A clinical perspective. Gene Ther. 2, 88-95.
3. BARGON, J., TRAPNELL, B.C., CHU, C.S., ROSENTHAL, E.R., YOSHIMURA, K., GUGGINO, W.B., DALEMANS, W., PAVIRANI, A., LECOCQ, J.P., and CRYSTAL, R.G. (1992). Down-regulation of cystic fibrosis transmembrane conductance regulator gene expression by agents that modulate intracellular divalent cations. Mol. Cell. Biol. 12, 1872-1878.
4. BEZANÇON, P., PRZEWLOCKI, G., BARO, I., HONGRE, A.S., ESCANDE, D., and EDELMNA, A. (1994). Interferon gamma down-regulated CFTR gene expression in epithelial cells. Am. J. Physiol. 267, C1398-1404.
5. BOAT, T.F., WELSH, M.J., and BEAUDET, A.L. (1989). Cystic fibrosis. In The Metabolic Basis of Inherited Disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, eds. (McGraw-Hill Inc., New York), pp. 2649-2680.
6. BOUT, A., PERRICAUDET, M., BASKIN, G., IMLER, J.L., SCHOLTE, B.J., PAVIRANI, A., and VALERIO, D. (1994a). Lung gene therapy: In vivo adenovirus mediated gene transfer to rhesus monkey airway epithelium. Hum. Gene Ther. 5, 3-10.
7. BOUT, A., IMLER, J.L., SCHULTZ, H., PERRICAUDET, M., ZURCHER, C., HERBRINK, P., VALERIO, D., and PAVIRANI, A. (1994b). In vivo adenovirus-mediated transfer of human CFTR cDNA to rhesus monkey airway epithelium: Efficacy, toxicity and safety. Gene Ther. 1, 385-394.
8. BREZILLON, S., DUPUIT, F., HINNRASKY, J., MARCHAND, V., KALIN, N., TUMMLER, B., and PUCHELLE, E. (1995). Decreased expression of the CFTR protein in remodeled human nasal epithelium from non-cystic fibrosis patients. Lab. Invest. 72, 191-200.
9. CRYSTAL, R.G., MCELVANEY, N.G., ROSENFELD, M.A., CHU, C.S., MASTRANGELI, A., HAY, J.G., BRODY, S.L., JAFFE, A.H., EISSA, N.T., and DANEL, C. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8, 42-51.
10. DELANEY, S.J., RICH, D.P., THOMSON, S.A., HARGRAVE, M.R., LOVELOCK, P.K., WELSH, M.J., and WAINWRIGHT, J. (1993). Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channels. Nat. Genet. 4, 426-431.
11. DUPUIT, F., KALIN, N., BREZILLON, S., HINNRASKY, J., TUMMLER, B., and PUCHELLE, E. (1995a). CFTR and differentiation markers expression in non-CF and ΔF508 homozygous CF nasal epithelium. J. Clin. Invest. 96, 1601-1611.
12. DUPUIT, F., ZAHM, J.M., PIERROT, D., BREZILLON, S., BONNET, N., IMLER, J.L., PAVIRANI, A., and PUCHELLE, E. (1995b). Regenerating cells in human airway surface epithelium represent preferential targets for recombinant adenovirus. Hum. Gene Ther. 6, 1185-1193.
13. GRAHAM, F.L., and PREVEC, L. (1991). Manipulation of adenovirus vectors. In Methods of Molecular Biology, vol. 7. E.J. Murray, ed. (The Humana Press Inc, Clifton, NJ) pp. 109-128.
14. GRUBB, B., PICKLES, R.J., YE, H., YANKASKAS, J.R., VICK, R.N., ENGELHARDT, J.F., WILSON, J.M., JOHNSON, L.G., and BOUCHER, R.C. (1994). Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 371, 802-806.
15. HAMOSH, A., TRAPNELL, B.C., ZEITLIN, P.L., MONTROSER-AFIZADEH, C., ROSENSTEIN, B.J., CRYSTAL, R.G., and CUTTING, G.R. (1991). Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis. J. Clin. Invest. 88, 1880-1885.
16. HAY, J.G., MCELVANEY, N.G., HERENA, J., and CRYSTAL, R.G. (1995). Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local adminstration of a normal CFTR cDNA adenovirus gene transfer vector. Hum. Gene Ther. 6, 1487-1496.
17. HORWITZ, M.S. (1990). Adenoviridae and their replication. In Virology, 2 ed. B.N. Field and D.M. Knipe, eds. (Raven Press, New York) pp. 1679-1721.
18. IMLER, J.L., BOUT, A., PERRICAUDET, M., BASKIN, G., SCHOLTE, B., PAVIRANI, A., and VALERIO, D. (1993). Lung specific gene therapy. In Clinical Ecology of Cystic Fibrosis. H. Escobar, F. Baquero, and L. Suarez, eds. (Elsevier Science Publishers B.V., Amsterdam, The Netherlands) pp. 21-25.
19. IMLER, J.L., BOUT, A., DREYER, D., DIETERLE, A., SCHULTZ, H., VALERIO, D., MEHTALI, M., and PAVIRANI, A. (1995). Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses. Hum. Gene Ther. 6, 711-721.
20. KEREM, B.S., ROMMENS, J.M., BUCHANAN, J.A., MARKIEWICZ, D., COX, T.K., CHAKRAVARTI, A., BUCHWALD, M., and TSUI, L.-C. (1989). Identification of the cystic fibrosis gene: Genetic analysis. Science 245, 1073-1080.
21. KNOWLES, M.R., PARADISO, A.M., and BOUCHER, R.C. (1995a). In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum. Gene Ther. 6, 445-455.
22. KNOWLES, M.R., HOHNEKER, K., ZHOU, Z., OLSEN, J.C., NOAH, T.L., HU, P.C., LEIGH, M.W., ENGELHARDT, J.F., EDWARDS, L.J., JONES, K.R., GROSSMAN, M.. WILSON, J.M., JOHNSON, L.G., and BOUCHER, R.C. (1995b). A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N. Engl. J. Med. 333, 823-831.
23. KORST, R.J., MCELVANEY, N.G., CHU, C.-S., ROSENFELD, M.A., MASTRANGELI, A., HAY, J., BRODY, S.L., EISSA, N.T., DANEL, C., JAFFE, H.A., and CRYSTAL, R.G. (1995). Gene therapy for the respiratory manifestations of cystic fibrosis. Am. J. Respir. Crit. Care Med. 151, 575-587.
24. LABBÉ, A., BELLON, G., HERAUD, M.C., ARBRE, P., and ALTON, E. (1991). Détermination des différences de potential transépithélial nasal dans la mucoviscidose: Analyse d'une méthode de mesure simplifié. Arch. Fr. Pédiatr. 48, 617-620.
25. MCELVANEY, N.G., and CRYSTAL, R.G. (1995). IL-6 release and airway administration of human CFTR cDNA adenovirus vector. Nature Med. 1, 182-184.
26. MOREL, Y., ANDRE, J., URING-LAMBERT, B., HAUPTMANN, G., BETUEL, H., TOSI, M., FOREST, M.G., DAVID, M., BERTRAND, J., and MILLER, W.L. (1989). Rearrangements and point mutations of P450c21 genes are distinguished by five restriction endonuclease haplotypes identified by a new probing strategy in 57 families with congenital adenal hyperplasia. J. Clin. Invest. 83, 527-536.
27. NAKAMURA, H., YOSHIMURA, K., BAJOCCHI, G., TRAPNELL, B.C., PAVIRANI, A., and CRYSTAL, R.G. (1992). Tumor necrosis factor modulation of expression of the cystic fibrosis transmembrane conductance regulator gene. FEBS Lett. 314, 366-370.
28. O'NEAL, W.K., and BEAUDET, A.L. (1994). Somatic gene therapy for cystic fibrosis. Hum. Mol. Genet. 3, 1497-1502.
29. RICHARDSON, P.S., and ALTON, E.W.F.W. (1993). Cystic fibrosis transmembrane conductance regulator protein: What is its role in cystic fibrosis? Eur. Respir. J. 6, 160-162.
30. RIORDAN, J.R., ROMMENS, J.M., KEREM, B.S., ALON, N., ROZMAHEL, R., GRZELCZAK, Z., ZIELENSKI, J., LOK, S., PLAVSIC, N., CHOU, J.L., DRUMM, M.L., IANNUZZI, M.C., COLLINS, F.S., and TSUI, L.C. (1989). Identification of the cystic fibrosis gene cloning and characterization of complementary DNA. Science 245, 1066-1073 [Erratum, Science 245, 1437, 1989].
31. ROMMENS, J.M., IANNUZZI, M.C., KEREM, B.S., DRUMM, M.L., MELMER, G., DEAN, M., ROZMAHEL, R., COLE, J.L., KENNEDY, D., HIDAKA, N., ZSIGA, M., BUCHWALD, M., RIORDAN, J.R., TSUI, L.C., and COLLINS, F.S. (1989). Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245, 1059-1065.
32. ROSENFELD, M.A., YOSHIMURA, K., TRAPNELL, B.C., YONEYAMA, K., ROSENTHAL, E.R., DALEMANS, W., FUKAYAMA, M., BARGON, J., STIER, L.E., STRATFORD-PERRICAUDET, L., PERRICAUDET, M., GUGGINO, W.B., PAVIRANI, A., LECOCQ, J.P., and CRYSTAL, R.G. (1992). In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143-155.
33. SENE, C., BOUT, A., IMLER, J.L., SCHULTZ, H., WILLEMOT, J.M., HENNEBEL, V., ZURCHER, C., VALERIO, D., LAMY, D., and PAVIRANI, A. (1995). Aerosol-mediated delivery of recombinant adenovirus to the airways of nonhuman primates. Hum. Gene Ther. 6, 1595-1601.
34. STRAUSS, S.E. (1984). Adenovirus infection in humans. In The Adenoviruses. H.S. Ginsberg, ed. (Plenum, New York) pp. 451-496.
35. TRAPNELL, B.C., ZEITLIN, P.L., CHU, C.S., YOSHIMURA, K., NAKAMURA, H., GUGGINO, W.B., BARGON, J., BANKS, T.C., DALEMANS, W., PAVIRANI, A., LECOCQ, J.P., and CRYSTAL, R.G. (1991). Down-regulation of cystic fibrosis gene mRNA transcript levels and induction of the cystic fibrosis chloride secretory phenotype in epithelial cells by phorbol ester. J. Biol. Chem. 266, 10319-10323.
36. WELSH, M.J., and SMITH, A.E. (1993). Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73, 1251-1254.
37. YOSHIMURA, K., NAKAMURA, H., TRAPNELL, B.C., DALEMANS, W., PAVIRANI, A., LECOCQ, J.P., and CRYSTAL, R. (1991). The cystic fibrosis gene has a "housekeeping"-type promoter and is expressed at low levels in cells of epithelial origin. J. Biol. Chem. 266, 9140-9144.
38. ZABNER, J., COUTURE, L.A., GREGORY, R.J., GRAHAM, S.M., SMITH, A.E., and WELSH, M.J. (1993). Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75, 207-216.
39. ZABNER, J., RAMSEY, B.W., MEEKER, D.P., AITKEN, M.L., BALFOUR, R.P., GIBSON, R.L., LAUNSPACH, MOSCICKI, R.A., RICHARDS, S.M., STANDAERT, T.A., WILLIAMS-WARREN, J., WADSWORTH, S.C., SMITH, A.E., and WELSH, M.J. (1996). Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J. Clin. Invest. 97, 1504-1511.